Matthew F Wipperman

Matthew F Wipperman

Regeneron Pharmaceuticals Inc - Warsaw / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4417773
-
person_outline Matthew F Wipperman's MOST POPULAR ARTICLES
1-) Dupilumab in adults and adolescents with eosinophilic esophagitisES Dellon, ME Rothenberg, MH Collins, I Hirano, M Chehade, ...New England Journal of Medicine 387 (25), 2317-2330, 20221882022
2-) Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completedMF Wipperman, DW Fitzgerald, MAJ Juste, Y Taur, S Namasivayam, ...Scientific reports 7 (1), 10767, 20171812017
3-) Pathogen roid rage: Cholesterol utilization by Mycobacterium tuberculosisMF Wipperman, NS Sampson, ST ThomasCritical Reviews in Biochemistry and Molecular Biology 49 (4), 269-293, 20141742014
4-) Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapyS Namasivayam, M Maiga, W Yuan, V Thovarai, DL Costa, LR Mittereder, ...Microbiome 5, 1-17, 20171482017
5-) The microbiome and tuberculosis: early evidence for cross talkS Namasivayam, A Sher, MS Glickman, MF WippermanMBio 9 (5), 10.1128/mbio. 01420-18, 201879*2018